| Application no. and date | 23155431.2 (espacenet) (Federated) (European Patent Register), 20230207 | | Patent/reg. no. and date | DK/EP 4413976, 20250813 | | Publication date | 20240814 | | Priority no. and date | | | EP pub. no. and date |
EP 4413976 20240814 | | Effective date | | | Applicant/owner | Santhera Pharmaceuticals (Schweiz) AG, Hohenrainstrasse 24
4133 Pratteln, CH | | Applicant ref. no. | | | Inventor | ALLIERI, Brigida,
37138 Verona, IT,
CHALLIS, Bradley,
Nottingham, NG10 2BJ, GB,
CHOPRA, Reenu,
Nottingham, NG12 4HX, GB,
DIAZ, Liliana,
4125 Riehen, CH,
HAUSMANN, Rudolf,
4052 Basel, CH | | Representative | | | Opponent | | | IPC Class | A61K 31/5685 (2006.01) , A61K 31/573 (2006.01) , A61K 9/14 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) | | Title | A NEW VAMOROLONE PREPARATION EXHIBITING IMPROVED SOLUBILITY | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
